5 Slides: The policy implications of new medicines
Nicole Pasia | Feb 10, 2022 | Florida
5 Slides We're Discussing: Overcoming Vaccine Hesitancy
Aaron Kunkler | Jan 26, 2022 | Alaska
5 Slides We're Discussing: Bending the Rx Cost Curve
Aaron Kunkler | Jan 20, 2022 | Federal
Video: Gene therapy and the promise for rare disease
Eli Kirshbaum | Nov 17, 2021 | California
5 Slides We're Discussing: The policy implications of new medicines
Patrick Jones | Nov 17, 2021 | Illinois, Michigan
Panelists discussed the importance of transparency and need for cost reductions on specialty drugs in State of Reform’s recent virtual conversation “5 Slides We’re Discussing: The policy implications of new medicines.” The experts called on pharmaceutical companies and pharmacy benefit managers (PBMs) to be more transparent in their pricing and
Registration for "5 Slides: The policy implications of new medicines" is now open!
Patrick Jones | Nov 3, 2021 | Illinois, Michigan
The pandemic has shifted the politics and public opinion on health care. Where cost was a primary concern before COVID, now access to affordable innovations is top of consumers and policy makers minds. So, as a return to normalcy appears on the horizon, the intersection of cost pressures and innovation
Registration for “5 Slides: Bending the Rx cost curve” is now open!
Nicole Pasia | Oct 22, 2021 | Maryland
The question of increasing affordable access to care has risen to the forefront of health policy conversations in the wake of COVID-19 — a shift from previously cost-focused models. In the world of pharmacy, health leaders are engaging in conversations about navigating cost pressures as Virginia begins to, hopefully, return
Registration for “5 Slides: Gene therapy and the promise for rare diseases” is now open!
Emily Boerger | Oct 12, 2021 | Washington
Gene therapy represents a new generation of medicine that shows great promise in the fight against rare genetic diseases. The potential long-term transformative benefits could reduce, or even eliminate the ongoing costs of supporting patients and managing diseases. State of Reform is looking forward to exploring this issue in depth at
Registration Open: "5 Slides We're Discussing" Strengthening the behavioral health system
Patrick Jones | May 25, 2021 | Oregon
Oregon’s suicide death rate is the 9th highest in the country, according to CDC statistics. The COVID-19 pandemic has only exacerbated those struggles as more adults are reporting anxiety and depression. What can we do in Oregon to augment our behavioral and mental health system while maintaining a financially healthy
Registration open—reviewing health policy in the 2021 Oregon legislature
Matt Beuschlein | Apr 15, 2021 | Oregon
Some of Oregon's most influential voices in health policy advocacy will be joining State of Reform on April 23rd. They will be reviewing the progress made during the legislative session and talk through some key policy conversations. During our upcoming Leadership Series, “Reviewing health policy in the 2021 Oregon Legislature”,